Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Aimmune Nestlé Health Science Us R&d, Llc

Clinical trials sponsored by Aimmune Nestlé Health Science Us R&d, Llc, explained in plain language.

Now part of Nestlé S.A. NSRGY OTC

Aimmune is a biopharmaceutical company focused on developing treatments for food allergies, now part of Nestlé Health Science.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Not yet recruiting 1

New enzyme could help digest food for those with pancreatic problems

Disease control Not yet recruiting

This study tests a new lab-made enzyme called NHS7108 in people with exocrine pancreatic insufficiency (EPI), a condition where the pancreas doesn't make enough enzymes to digest food. About 66 adults will take either NHS7108 or the standard enzyme Zenpep for 14 days each, while …

Phase: PHASE2 • Sponsor: Aimmune Nestlé Health Science US R&D, LLC • Aim: Disease control

Last updated Jun 27, 2026 12:26 UTC